Emulsi Biotech AB, a Swedish biotechnology company specializing in lipid-based excipients for oral drug delivery. Our NanoLIPID™ platform utilizes self-assembling lipids to enhance the bioavailability of peptides and biologics. With a focus on natural, food-grade, and pharmaceutical-grade NanoLIPID™ formulations, we develop excipients designed to protect drugs in the gastrointestinal environment and enable controlled release.
